北美血脑屏障技术市场预测至 2028 年 - COVID-19 影响和技术区域分析（双特异性抗体 RMT 方法、特洛伊木马方法、增加渗透性、被动扩散和其他非侵入性 BBB 技术）和应用（阿尔茨海默氏症™）病、癫痫、帕金森病、多发性硬化症、亨特综合症、脑癌等）
市场介绍
北美血脑屏障技术由美国、加拿大、和墨西哥。美国是北美血脑屏障技术的最大市场。据估计，美国血脑屏障技术市场是该地区最大的市场，并且在预测年内可能会继续占据主导地位。由于基础设施完善，阿尔茨海默病、癫痫、帕金森病、多发性硬化症、亨特综合症、脑癌等神经系统疾病的患病率不断增加，全国市场预计将增长。例如，根据美国临床肿瘤学会 (ASCO) 的数据，到 2021 年，美国估计将有 24,530 名成年人（13,840 名男性和 10,690 名女性）被诊断患有原发性脑部和脊髓癌性肿瘤。在人的一生中，患这种肿瘤的几率不到 1%。大多数原发性中枢神经系统 (CNS) 恶性肿瘤是脑肿瘤，占所有病例的 85% 至 90%。市场参与者正在采用有机和无机增长策略来开发市场。例如，2021 年 6 月，美国食品和药物管理局 (FDA) 授予礼来公司用于治疗阿尔茨海默病 (AD) 的多纳单抗抗体疗法的突破性技术称号。因此，由于上述因素，预计血脑屏障技术市场在预测年内可能会呈指数级增长。同样，2021年6月，美国食品和药物管理局批准辉瑞公司的Aduhelm（aducanumab）用于治疗阿尔茨海默病。 Aduhelm 通过加速审批途径获得批准，可用于治疗严重或危及生命的疾病的药物，与现有治疗方法相比，提供有意义的治疗优势此外，2020 年 10 月，百时美施贵宝宣布加拿大卫生部批准了 ZEPOSIA（ozanimod） ）用于治疗复发缓解型多发性硬化症 (RRMS) 患者，以降低临床恶化的频率。
多个市场都感受到了 COVID-19 的全球影响。尽管医疗保健行业在过去几年中经历了 SARS、H1N1 和其他疫情的爆发，但 COVID-19 的严重性因其传播方式而使情况变得更加复杂。 2020 年 12 月发表的新研究表明，COVID-19 可以穿过血脑屏障。这一发现为许多抱怨在感染疾病后很久仍存在认知副作用的患者提供了证据。西雅图华盛顿大学医学院的研究人员领导了这项研究，研究了冠状病毒刺突蛋白在小鼠体内的行为。他们发现，这种 S1 蛋白可以穿过血脑屏障并抓住其他细胞受体，这可能对脑组织有毒。
市场概述与动态
北美血脑屏障技术市场预计将从2021年的3.9156亿美元增长到19.3623亿美元到 2028 年；预计 2021 年至 2028 年复合年增长率为 25.7%。治疗脑相关疾病的有效药物输送具有挑战性。原因是中枢神经系统中存在障碍，例如血脑屏障。由脑毛细血管内皮细胞形成的血脑屏障限制了大多数药物和递送系统的进入。血脑脊液屏障和血液肿瘤屏障也给中枢神经系统（CNS）有效递送治疗剂带来了巨大问题。因此，市场参与者正在推出各种技术，如分子特洛伊木马技术、基于生物学的方法、血脑屏障破坏、立体定向插入、鼻内递送、化学方法和转运介导的递送，以提高大脑中治疗化合物的数量和浓度。近年来发生了一些与血脑屏障技术市场相关的最新发展。例如，2019 年 1 月，美国食品和药物管理局 (FDA) 批准了梯瓦制药工业公司美国子公司生产的第一个仿制药 Sabril（氨己烯酸）片剂，用于治疗复杂部分性癫痫发作，作为附加疗法患者。此外，2021年6月，美国FDA授予礼来公司开发的用于治疗阿尔茨海默病（AD）的donanemab抗体疗法突破性疗法称号。因此，市场参与者积极参与产品创新和开发以及产品批准的增加可能会推动未来几年的市场增长
主要细分市场
从技术角度来看，渗透率提高细分市场在北美占据最大份额2021年血脑屏障技术市场。从应用来看，帕金森病细分市场占据2021年北美血脑屏障技术市场的最大份额。
主要来源和上市公司
参考的一些主要一手和二手来源准备这份关于北美血脑屏障技术市场的报告包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司有梯瓦制药工业有限公司（Teva Pharmaceutical Industries Ltd.）； F.霍夫曼-拉罗氏有限公司；礼来公司；百时美施贵宝公司；辉瑞公司；强生公司约翰逊服务公司；法布尔-克莱默制药公司；和 Bioasis Technologies, Inc. 等。
购买报告的理由
- 了解北美血脑屏障技术市场格局并确定最有可能保证的细分市场强劲回报
- 了解北美血脑屏障技术市场不断变化的竞争格局，保持领先地位
- < span>通过识别最有可能销售前景的细分市场，有效规划北美血脑屏障技术市场的并购和合作交易
- 帮助从敏锐的洞察力中做出明智的业务决策并对北美血脑屏障技术市场各个细分市场的市场表现进行综合分析
- 获取北美地区2021-2028年各个细分市场的市场收入预测.
北美血脑屏障技术市场细分
北美血脑屏障技术市场 -按技术
- 双特异性抗体RMT方法
- 特洛伊木马方法
- 增加渗透性
- 被动扩散
- 其他非侵入性 BBB 技术
北美血脑屏障技术市场 -通过应用
- 阿尔茨海默病
- 癫痫
- 帕金森病
- 多发性硬化症
- 猎人综合症
- 脑癌
- 其他 >
北美血脑屏障技术市场 -按国家/地区
- 美国
- 加拿大
- 墨西哥
北美血脑屏障技术市场——提及的公司
- 梯瓦制药工业有限公司 ;
- F.霍夫曼拉罗氏有限公司 ;
- 礼来公司和公司 ; &n公共服务提供商; &n公共服务提供商;
- 百时美施贵宝公司 ; &n公共服务提供商;
- 辉瑞公司 ; &n公共服务提供商; &n公共服务提供商;
- 强生公司约翰逊服务公司 ;
- Fabre-Kramer Pharmaceuticals, Inc. ; &n公共服务提供商;
- Bioasis Technologies, Inc.
;
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Blood Brain Barrier Technologies Market – By Technology
1.3.2 North America Blood Brain Barrier Technologies Market – By Application
1.3.3 North America Blood Brain Barrier Technologies Market– By Country
2. North America Blood Brain Barrier Technologies Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Blood Brain Barrier Technologies Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Experts Opinion
5. North America Blood Brain Barrier Technologies Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Raising Prevalence of Neurological Disorders
5.1.2 Growing Geriatric Population and Rising Prevalence of Age-Associated Neurological Disorders
5.2 Market Restraints
5.2.1 Issues in Brain Medication Delivery
5.3 Market Opportunities
5.3.1 Vast Number of Product Approvals and Launches
5.4 Future Trends
5.4.1 Raising Demand of Nanoparticles for Brain Drug Delivery
5.5 Impact Analysis
6. North America Blood Brain Barrier Technologies – Market Analysis
6.1 North America Blood Brain Barrier Technologies Market Revenue Forecast and Analysis
7. North America Blood Brain Barrier Technologies Market Analysis – by Technology
7.1 Overview
7.2 Blood Brain Barrier Technologies Market, by Technology 2021 & 2028 (%)
7.3 Bispecific Antibody RMT Approach
7.3.1 Overview
7.3.2 Bispecific Antibody RMT Approach: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Trojan Horse Approach
7.4.1 Overview
7.4.2 Trojan Horse Approach: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Increasing Permeability
7.5.1 Overview
7.5.2 Increasing Permeability: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Passive Diffusion
7.6.1 Overview
7.6.2 Passive Diffusion: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Other Non-Invasive BBB Technologies
7.7.1 Overview
7.7.2 Other Non-Invasive BBB Technologies: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
8. North America Blood Brain Barrier Technologies Market Analysis – By Application
8.1 Overview
8.2 Blood Brain Barrier Technologies Market, by Application 2021 & 2028 (%)
8.3 Alzheimer’s Disease
8.3.1 Overview
8.3.2 Alzheimer’s Disease: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Epilepsy
8.4.1 Overview
8.4.2 Epilepsy: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Parkinson’s Disease
8.5.1 Overview
8.5.2 Parkinson’s Disease: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Multiple Sclerosis
8.6.1 Overview
8.6.2 Multiple Sclerosis: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Hunter’s Syndrome
8.7.1 Overview
8.7.2 Hunter’s Syndrome: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Brain Cancer
8.8.1 Overview
8.8.2 Brain Cancer: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
8.9 Others
8.9.1 Overview
8.9.2 Others: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
9. North America Blood Brain Barrier Technologies Market – Country Analysis
9.1 Overview
9.1.1 North America: Blood Brain Barrier Technologies Market, by Country, 2021 & 2028 (%)
9.1.1.1 US: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.1 US: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.2 US Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.3 US Blood Brain Barrier Technologies Market, by Application– Revenue and Forecast to 2028 (USD Million)
9.1.1.2 Canada: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.1 Canada: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.2 Canada Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.3 Canada Blood Brain Barrier Technologies Market, by Application– Revenue and Forecast to 2028 (USD Million)
9.1.1.3 Mexico: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.1 Mexico: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.2 Mexico Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.3 Mexico Blood Brain Barrier Technologies Market, by Application– Revenue and Forecast to 2028 (USD Million)
10. Impact Of COVID-19 Pandemic on North America Blood Brain Barrier Technologies Market
10.1 Impact Assessment of COVID-19 Pandemic
11. North America Blood Brain Barrier Technologies Market– Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 Teva Pharmaceutical Industries Ltd.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Eli Lilly and Company
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Bristol-Myers Squibb Company
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Pfizer, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Johnson and Johnson Services, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Fabre-Kramer Pharmaceuticals, Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Bioasis Technologies, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Blood Brain Barrier Technologies Market – Revenue, and Forecast to 2028 (US$ Million)
Table 2. US Blood Brain Barrier Technologies Market, by Technology – Revenue and Forecast to 2028 (USD Million)
Table 3. US Blood Brain Barrier Technologies Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 4. Canada Blood Brain Barrier Technologies Market, by Technology -Revenue and Forecast to 2028 (USD Million)
Table 5. Canada Blood Brain Barrier Technologies Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 6. Mexico Blood Brain Barrier Technologies Market, by Technology -Revenue and Forecast to 2028 (USD Million)
Table 7. Mexico Blood Brain Barrier Technologies Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 8. Organic Developments Done By Companies
Table 9. Inorganic Developments Done By Companies
Table 10. Glossary of Terms, Blood Brain Barrier Technologies Market
LIST OF FIGURES
Figure 1. North America Blood Brain Barrier Technologies Market Segmentation
Figure 2. North America Blood Brain Barrier Technologies Market Segmentation, By Country
Figure 3. North America Blood Brain Barrier Technologies Market Overview
Figure 4. Increasing Permeability Segment Held the Largest Share by Technology in Blood Brain Barrier Technologies Market
Figure 5. U.S. to Show Significant Growth During Forecast Period
Figure 6. North America Blood Brain Barrier Technologies Market, Industry Landscape
Figure 7. North America PEST Analysis
Figure 8. North America Blood Brain Barrier Technologies Market– Revenue Forecast and Analysis – 2021 - 2028
Figure 9. Blood Brain Barrier Technologies Market, by Technology 2021 & 2028 (%)
Figure 10. Bispecific Antibody RMT Approach: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Trojan Horse Approach: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Increasing Permeability: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Passive Diffusion: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Other Non-Invasive BBB Technologies: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Blood Brain Barrier Technologies Market, by Application 2021 & 2028 (%)
Figure 16. Alzheimer’s Disease: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Epilepsy: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Parkinson’s Disease: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Multiple Sclerosis: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Hunter’s Syndrome: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Brain Cancer: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. North America: Blood Brain Barrier Technologies Market, by Key Country – Revenue (2021) (USD Million)
Figure 24. North America: Blood Brain Barrier Technologies Market, by Country, 2021 & 2028 (%)
Figure 25. US: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
Figure 26. Canada: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
Figure 27. Mexico: Blood Brain Barrier Technologies Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. Impact of COVID-19 Pandemic in North American Country Markets- Teva Pharmaceutical Industries Ltd.
- F. Hoffmann-La Roche Ltd
- Eli Lilly and Company
- Bristol-Myers Squibb Company
- Pfizer, Inc.
- Johnson & Johnson Services, Inc.
- Fabre-Kramer Pharmaceuticals, Inc.
- Bioasis Technologies, Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America blood brain barrier technologies market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America blood brain barrier technologies market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the blood brain barrier technologies market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution